tradingkey.logo

Beta Bionics Inc

BBNX

16.420USD

+0.020+0.12%
Close 08/04, 16:00ETQuotes delayed by 15 min
703.75MMarket Cap
LossP/E TTM
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024Q4
FY2023Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-124.97%-14.28M
---6.35M
Net income from continuing operations
3.93%-18.11M
---18.85M
Operating gains losses
-2.76%529.00K
--544.00K
Other non-cash items
-41.98%-1.04M
---736.00K
Change in working capital
-472.97%-3.24M
---566.00K
-Change in receivables
-84.01%-4.56M
---2.48M
-Change in inventory
-72.16%-1.58M
---916.00K
-Change in prepaid expenses
-308.70%-1.13M
---276.00K
-Change in other current assets
103.45%1.00K
---29.00K
-Change in other current liabilities
228.99%783.00K
--238.00K
Cash from non-recurring investing activities
Cash from operating activities
-124.97%-14.28M
---6.35M
Investing cash flow
Net cash from continuing investing activities
79.23%561.00K
--313.00K
Capital expenditures
79.23%561.00K
--313.00K
Net cash flow from disposal of fixed assets
79.23%561.00K
--313.00K
Net cash flow from investment products
58.00%-29.10M
---69.30M
Net cash flow from other investing activities
--0.00
----
Cash from non-current investing activities
Net cash flow from investing activities
57.39%-29.66M
---69.61M
Financing cash flow
Cash flow from continuous financing activities
632033.33%56.89M
--9.00K
Net cash flow from preferred stock issuance/repurchase
--59.66M
--0.00
Proceeds from stock option exercised by employees
311.11%37.00K
--9.00K
Proceeds from issuance of warrants
--1.00K
--0.00
Net cash flow from other financing activities
---2.81M
----
Net cash from non-recurrent financing activities
Net cash from financing activities
632033.33%56.89M
--9.00K
Net cash flow
Beginning cash balance
-82.87%17.58M
--102.61M
Current period cash flow changes
117.05%12.95M
---75.95M
Ending cash balance
14.50%30.53M
--26.67M
Free cash flow
-122.82%-14.84M
---6.66M
Currency unit
USD
USD
Audit opinions
--
--
KeyAI